Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02345954
Other study ID # lapSKPvslapHP
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 2015
Est. completion date October 2023

Study information

Verified date September 2020
Source Kantonsspital Aarau
Contact Dimitri Sarlos, MD
Phone +41 838 5065
Email dimitri.sarlos@ksa.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the operative, anatomic functional outcome as well as the subjective outcome of laparoscopic supracervical hysterectomy and sacropexy compared to laparoscopic hysteropexy (conserving the uterus).

The investigators expect that both laparoscopic procedures are equal in regards to operation time, complication rate, anatomic and functional outcome as well as subjective outcome.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date October 2023
Est. primary completion date October 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients older than 18 years

- Symptomatic uterus prolapse (uterus < 300g)

- Patient able to sign the informed consent and to fulfil the follow up visits

Exclusion Criteria:

- Indication: Pathologies of the uterus (postmen. bleeding, high endometrium at ultrasound (>5 mm), abnormal PAP smear in the last 5 years, bleeding anomalies in premenopausal patients

- General medical contraindications to a surgical operation

- tumor/ malignant disease

- bacterial infection at time of surgery

- drug or medication abuse at time or just before surfer

- Disease which would make a correct assessment of the patient impossible (e.g. psychiatric condition)

- Known hypersensitivity to the implanted materials

- Immaturity, inability to answer/understand questions

- Planned pregnancy

- Participation to other studies (drugs or medical techniques) which could influence the results of this study

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Laparoscopic Supracervical Hysterectomy and Sacropexy
Laparoscopic supracervical hysterectomy and laparoscopic sacrocolpopexy
Laparoscopic Hysteropexy
Laparoscopic hysteropexy

Locations

Country Name City State
Switzerland Kantonsspital Aarau Aarau Aargau (AG)

Sponsors (1)

Lead Sponsor Collaborator
Kantonsspital Aarau

Country where clinical trial is conducted

Switzerland, 

References & Publications (5)

Khunda A, Vashisht A, Cutner A. New procedures for uterine prolapse. Best Pract Res Clin Obstet Gynaecol. 2013 Jun;27(3):363-79. doi: 10.1016/j.bpobgyn.2012.12.004. Epub 2013 Jan 5. Review. — View Citation

Krause HG, Goh JT, Sloane K, Higgs P, Carey MP. Laparoscopic sacral suture hysteropexy for uterine prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun;17(4):378-81. Epub 2005 Nov 30. — View Citation

Price N, Slack A, Jackson SR. Laparoscopic hysteropexy: the initial results of a uterine suspension procedure for uterovaginal prolapse. BJOG. 2010 Jan;117(1):62-8. doi: 10.1111/j.1471-0528.2009.02396.x. — View Citation

Sarlos D, Kots L, Stevanovic N, von Felten S, Schär G. Robotic compared with conventional laparoscopic hysterectomy: a randomized controlled trial. Obstet Gynecol. 2012 Sep;120(3):604-11. doi: 10.1097/AOG.0b013e318265b61a. — View Citation

Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol. 2009 Dec;114(6):1278-83. doi: 10.1097/AOG.0b013e3181c2ce96. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Operation time Comparison of operation time in the 2 arms of the study expected average of 150 minutes
Secondary Intra- and postoperative complication rate 1 year
Secondary Duration of anaesthesia expected average of 200 minutes
Secondary IUGA Pelvic Organ Prolapse Quantification (POP-Q) 8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention
Secondary Bladder and bowel function, Prolapse symptoms, Sexuality Assessed via Pelvic Function Questionnaire 8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention
Secondary Quality of Life EQ-5D-5L questionnaire 8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention
Secondary Patient satisfaction after surgery At follow up 6 weeks, 6 months and 12 months after intervention